Regeneration Biomedical, Inc. (“RBI”), based in Newport Beach, CA, is in the clinical research stage of development of a novel treatment for neurodegenerative diseases. Leveraging over 30 years of medical and research experience, RBI focuses on stem cell therapy development and clinical application. RBI's innovative technique involves injecting Wnt-activated autologous stem cells directly into the brain bypassing the blood brain barrier to maximize activity. These highly purified, Wnt-activated autologous stem cells are expected to support activation and maintenance of stem cells in regenerative regions of the brain and reduce inflammation, which is associated with neurodegenerative diseases.
Company Details
- Employees
- 5
- Address
- 3900 W Coast Hwy, Newport Beach,california 92663,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Newport Beach, California
Regeneration Biomedical, Inc. Questions
Regeneration Biomedical, Inc.'s website is http://regenerationbiomedical.com
Regeneration Biomedical, Inc.'s LinkedIn profile is https://www.linkedin.com/company/regeneration-biomedical-inc
Regeneration Biomedical, Inc. has
5 employees.
View email and phone details for 5
employees at Regeneration Biomedical, Inc..
Regeneration Biomedical, Inc.'s industry is
Biotechnology Research
Regeneration Biomedical, Inc.'s top competitors are
Alloy Therapeutics, Inc.,
Biocardia, Inc.,
Interius Biotherapeutics,
Mathnasium Of Guilford,
Jetty 14 Design Group,
Poltreg S.a.,
Purespring Therapeutics,
Regeneration Biomedical,
Genprex, Inc.,
Bel Health.
Regeneration Biomedical, Inc.'s categories are Biotechnology Research
